Results

Total Results: over 10,000 records

Showing results for "drugs".

241. Survey suggests possible downward trend in identifying key drugs/drug classes as high-alert medications. | PSNet
     psnet.ahrq.gov/issue/survey-suggests-possible-downward-trend-identifying-key-drugsdrug-classes-high-alert
     July 30, 2014 - Newspaper/Magazine Article Survey suggests possible downward trend in identifying key drugs … Citation Text: Survey suggests possible downward trend in identifying key drugs/drug classes as high-alert … Citation Citation Text: Survey suggests possible downward trend in identifying key drugs … December 3, 2014 A mislabeling event with batched drugs: the unintended consequences … Care Providers Quality and Safety Professionals Medicine Pharmacy Specific to High-Risk Drugs

242. Adverse Drug Events in U.S. Hospitals, 2010 Versus 2014 (pdf file)
     hcup-us.ahrq.gov/reports/statbriefs/sb234-Adverse-Drug-Events.pdf
     June 01, 2016 - 7.2 8.9 24.1 Central nervous system drugs 1.1 1.0 7.6 7.2 –5.3 Autonomic nervous system drugs 0.7 … 0.7 4.9 4.6 –6.1 GI system drugs 0.4 0.4 2.8 2.8 –0.4 Skin, eye, and mucous membrane drugs 0.3 0.3 … Cardiovascular drugs Digoxin, antiadrenergics, and other cardiovascular drugs Water, mineral, and … uric acid metabolism drugs Saluretics, other diuretics, and other drugs affecting mineral and uric … drugs N/A Central nervous system drugs N/A Autonomic nervous system drugs N/A GI system drugs N/A

243. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/41118/psn-pdf
     February 08, 2012 - Preventability of adverse drug events involving multiple drugs using publicly available clinical decision … Preventability of adverse drug events involving multiple drugs using publicly available clinical decision … https://psnet.ahrq.gov/issue/preventability-adverse-drug-events-involving-multiple-drugs-using-publicly … https://psnet.ahrq.gov/issue/preventability-adverse-drug-events-involving-multiple-drugs-using-publicly-available-clinical … https://psnet.ahrq.gov/issue/preventability-adverse-drug-events-involving-multiple-drugs-using-publicly-available-clinical

244. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/35059/psn-pdf
     June 22, 2009 - Adverse events associated with sedatives, analgesics, and other drugs that provide patient comfort in … Adverse events associated with sedatives, analgesics, and other drugs that provide patient comfort in … https://psnet.ahrq.gov/issue/adverse-events-associated-sedatives-analgesics-and-other-drugs-provide- … https://psnet.ahrq.gov/issue/adverse-events-associated-sedatives-analgesics-and-other-drugs-provide-patient-comfort … https://psnet.ahrq.gov/issue/adverse-events-associated-sedatives-analgesics-and-other-drugs-provide-patient-comfort

245. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/40512/psn-pdf
     September 07, 2016 - Shortage of perioperative drugs: implications for anesthesia practice and patient safety. … Shortage of perioperative drugs: implications for anesthesia practice and patient safety. … https://psnet.ahrq.gov/issue/shortage-perioperative-drugs-implications-anesthesia-practice-and-patient … https://psnet.ahrq.gov/issue/shortage-perioperative-drugs-implications-anesthesia-practice-and-patient-safety … https://psnet.ahrq.gov/issue/shortage-perioperative-drugs-implications-anesthesia-practice-and-patient-safety

246. Intraoperative handoffs among anesthesia providers increase the incidence of documentation errors for controlled drugs. | PSNet
     psnet.ahrq.gov/issue/intraoperative-handoffs-among-anesthesia-providers-increase-incidence-documentation-errors
     April 12, 2019 - Intraoperative handoffs among anesthesia providers increase the incidence of documentation errors for controlled drugs … Intraoperative Handoffs Among Anesthesia Providers Increase the Incidence of Documentation Errors for Controlled Drugs … Intraoperative Handoffs Among Anesthesia Providers Increase the Incidence of Documentation Errors for Controlled Drugs … Providers Anesthesiology Discontinuities, Gaps, and Hand-Off Problems Specific to High-Risk Drugs

247. Primary Care Behavioral Interventions to Reduce Illicit Drug and Nonmedical Pharmaceutical Use (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/7dC6Dgb_adqNvnSd7U_FTu
     March 01, 2014 - Illegal drug use means taking drugs like cocaine, heroin, hallucinogens, inhalants, and marijuana. … or prescription drugs for nonmedical reasons. … Each day, about 4,300 teens start using drugs. … The use of illegal drugs and of medicines for nonmedical reasons has many negative effects: • • … illicit drug Illegal drugs such as cocaine, heroin, hallucinogens, inhalants, and marijuana.

248. Sb144
     meps.ahrq.gov/data_files/publications/st144/sb144.xml
     October 01, 2006 - and from 0.8 billion to 1.1 billion purchases for generic drugs. … (figure 1)
     
     Utilization of brand name prescribed drugs rose from 1.3 billion purchases to … Brand name drugs total expenditures increased from $75.5 billion to $141.0 billion, and generic drugs … For this brief, drugs falling into categories 1, 2, and 3 were considered brand name drugs, and drugs … falling into category 4 were considered generic drugs.

249. Sb110
     meps.ahrq.gov/data_files/publications/st110/sb110.xml
     January 01, 2006 - STATISTICAL BRIEF #110 January 2006 The Top Five Therapeutic Classes of Outpatient Prescription Drugs … In 2003, the top five therapeutic classes for adults when ranked by total expenses for prescription drugs … $110.4 billion and represented two-thirds (66.0 percent) of total expenditures spent on prescription drugs … , and the mean expenses in these classes of drugs. … Over-the-counter drugs and free samples are not included in these estimates.

250. Sb109
     meps.ahrq.gov/data_files/publications/st109/sb109.xml
     January 01, 2006 - STATISTICAL BRIEF #109 January 2006 The Top Five Therapeutic Classes of Outpatient Prescription Drugs … Statistical Brief provides a summary of the top five therapeutic classes of outpatient prescription drugs … , and the mean expenses in these classes of drugs. … Over-the-counter drugs and free samples are not included in these estimates. … (figure 4) Definitions/Methodology
     Therapeutic classes were assigned to drugs

251. Sb216-Appendix (pdf file)
     hcup-us.ahrq.gov/reports/statbriefs/sb216-appendix.pdf
     October 01, 2004 - causing adverse effects in therapeutic use E933.1 Antineoplastic and immunosuppressive drugs causing … Vitamin K [phytonadione] causing adverse effects in therapeutic use E934.4 Fibrinolysis-affecting drugs … , including sclerosing agents causing adverse effects in therapeutic use E942.8 Capillary-active drugs … substances E950.6 Suicide and self-inflicted poisoning by agricultural and horticultural chemical and pharmaceutical … preparations other than plant foods and fertilizers E950.7 Suicide and self-inflicted poisoning by

252. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/39511/psn-pdf
     November 02, 2010 - Prospective pilot intervention study to prevent medication errors in drugs administered to children … Prospective pilot intervention study to prevent medication errors in drugs administered to children … https://psnet.ahrq.gov/issue/prospective-pilot-intervention-study-prevent-medication-errors-drugs- administered-children … https://psnet.ahrq.gov/issue/prospective-pilot-intervention-study-prevent-medication-errors-drugs-administered-children … https://psnet.ahrq.gov/issue/prospective-pilot-intervention-study-prevent-medication-errors-drugs-administered-children

253. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/44389/psn-pdf
     August 19, 2015 - A method of addressing proprietary name similarity for US prescription drugs. … A Method of Addressing Proprietary Name Similarity for US Prescription Drugs. … https://psnet.ahrq.gov/issue/method-addressing-proprietary-name-similarity-us-prescription-drugs Health … https://psnet.ahrq.gov/issue/method-addressing-proprietary-name-similarity-us-prescription-drugs https … patient-safety-event-reporting-expectation-does-it-influence-residents-attitudes-and https://psnet.ahrq.gov/issue/look-alikesound-alike-drugs-literature-review-causes-and-solutions

254. Origin of Adverse Drug Events in U.S. Hospitals, 2011 (pdf file)
     hcup-us.ahrq.gov/reports/statbriefs/sb158.pdf
     August 11, 2013 - in the period from 1988– 1994, just over one-third of the elderly used three or more prescription drugs … of prescription medications is to help cure disease or alleviate symptoms; however, sometimes the drugs … , including hormones, analgesics, antibiotics, and cardiovascular drugs, among others.9 Adverse drug … The 2011 rates are reported for general classes as well as the specific types of drugs that cause ADEs … Insulin and hypoglycemics Other psychotropic drugs Central nervous system drugs Antidepressants

255. Final Progress Report: Advancing Patient Safety Innovation in Rheumatology (ASPIRE) (pdf file)
     www.ahrq.gov/sites/default/files/2024-02/yazdany-report.pdf
     January 01, 2024 - project was to characterize ambulatory medication safety events related to high-risk immunosuppressive drugs … informaticists, and measurement experts studied ambulatory patient safety for people using high-risk drugs … frequency and determinants of errors and adverse events for patients prescribed immunosuppressive drugs … The project generated new epidemiological evidence of patient safety risks and adverse events for drugs … ASPIRE reach program sought to address this gap by studying ambulatory patient safety errors for drugs

256. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/obesity_hi_impact.pdf
     April 17, 2012 - Antiobesity Drugs for Treatment of Obesity  Key Facts: Three drugs are in phase III development for … In December 2010, Arena Pharmaceuticals announced a plan to resubmit the lorcaserin NDA by the end … Arena Pharmaceuticals. Lorcaserin hydrochloride. Drugs Future 2007;32(9):766-70. 12. … Meta-analyses of phase 3 trials show obese and overweight patients taking Arena Pharmaceuticals' … Istanbul: Arena Pharmaceuticals, Inc.; 2011 May 26 [accessed 2011 Nov 16]. [3 p].

257. Obesity (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/obesity_hi_impact.pdf
     April 17, 2012 - Antiobesity Drugs for Treatment of Obesity  Key Facts: Three drugs are in phase III development for … In December 2010, Arena Pharmaceuticals announced a plan to resubmit the lorcaserin NDA by the end … Arena Pharmaceuticals. Lorcaserin hydrochloride. Drugs Future 2007;32(9):766-70. 12. … Meta-analyses of phase 3 trials show obese and overweight patients taking Arena Pharmaceuticals' … Istanbul: Arena Pharmaceuticals, Inc.; 2011 May 26 [accessed 2011 Nov 16]. [3 p].

258. Medication safety issue brief. Look-alike, sound-alike drugs. | PSNet
     psnet.ahrq.gov/issue/medication-safety-issue-brief-look-alike-sound-alike-drugs
     June 17, 2014 - Look-alike, sound-alike drugs. … Medication safety issue brief, look-alike, sound-alike drugs. Hospitals and Health Networks. … Medication safety issue brief, look-alike, sound-alike drugs. Hospitals and Health Networks. … See More About The Topic Health Care Providers Pharmacy Look-Alike, Sound-Alike Drugs

259. Adverse Drug Events in U.S. Hospitals, 2010 Versus 2014 #234
     hcup-us.ahrq.gov/reports/statbriefs/sb234-Adverse-Drug-Events.jsp
     January 01, 2018 - Autonomic nervous system drugs 0.7 0.7 4.9 4.6 -6.1 GI system drugs 0.4 0.4 … Systemic agents include antineoplastic drugs, antiallergy and antiemetic drugs, and other systemic agents … Cardiovascular drugs Digoxin, antiadrenergics, and other cardiovascular drugs Water, mineral … , and uric acid metabolism drugs Saluretics, other diuretics, and other drugs affecting mineral and … nervous system drugs N/A GI system drugs N/A Skin, eye, and mucous membrane drugs

260. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/41959/psn-pdf
     January 16, 2013 - Use of FMEA analysis to reduce risk of errors in prescribing and administering drugs in paediatric wards … Use of FMEA analysis to reduce risk of errors in prescribing and administering drugs in paediatric wards … https://psnet.ahrq.gov/issue/use-fmea-analysis-reduce-risk-errors-prescribing-and-administering-drugs … https://psnet.ahrq.gov/issue/use-fmea-analysis-reduce-risk-errors-prescribing-and-administering-drugs-paediatric-wards … https://psnet.ahrq.gov/issue/use-fmea-analysis-reduce-risk-errors-prescribing-and-administering-drugs-paediatric-wards